Welcome and thank you for considering submitting your work to Cell Metabolism. Established in 2005, Cell Metabolism is the top research journal dedicated to publishing novel, impactful papers spanning basic to clinical metabolic research. We are interested in original research addressing the molecular mechanisms underlying physiological homeostasis and what goes awry in disease.

The journal's mission is to provide the metabolic community a forum for the exchange of ideas and concepts and to promote cross-disciplinary research and collaboration. In line with this, we aim to publish work that is not only of exceptional significance within its field, but also of interest to researchers outside the immediate area, promoting idea cross-pollination.

Cell Metabolism's scope includes diabetes, obesity, pancreatic beta cell function, adipose tissue biology (white, brown, and beige), lipid metabolism, cardiovascular biology, immunometabolism, bone homeostasis, aging and stress responses, sarcopenia, intermediary metabolism and cancer, cachexia, neuronal control of metabolism and metabolic derangements causing neurodegeneration, circadian biology, stem cell energetics, exercise metabolism, the biology of mitochondria and other metabolic organelles such as peroxisomes and the ER, etc.

For original research articles, different formats are available such as "Research Article," "Short Article," "Clinical and Translational Report," and "Resource."

For non-research (front matter) articles, the formats include "Letter," "Essay," "Minireview," "Review," and "Perspective."

欢迎并感谢您考虑向 Cell Metabolism 提交您的作品。Cell Metabolism 成立于 2005 年，是顶级研究期刊，致力于发表涵盖基础到临床代谢研究的新颖、有影响力的论文。我们对原创研究感兴趣，这些研究涉及生理稳态背后的分子机制以及疾病的异常之处。

该期刊的使命是为代谢界提供一个交流思想和概念的论坛，并促进跨学科研究和合作。本着这一目标，我们的目标是发表不仅在领域内具有特殊意义，而且引起该领域以外研究人员兴趣的作品，促进思想交流。

《细胞代谢》的范围包括糖尿病、肥胖症、胰腺β细胞功能、脂肪组织生物学（白色、棕色和米色）、脂质代谢、心血管生物学、免疫代谢、骨稳态、衰老和应激反应、肌肉减少症、中间代谢和癌症、恶病质、神经元对代谢的控制和导致神经退行性的代谢紊乱、昼夜节律生物学、干细胞能量学、运动代谢、线粒体生物学和其他代谢细胞器如过氧化物酶体和内质网等。

对于原创研究文章，有不同的格式可供选择，如“研究文章”、“短文”、“临床和转化报告”和“资源”。

对于非研究（前言）文章，格式包括“信函”、“ “文章”、“迷你评论”、“评论”和“观点”。

该刊已被国际权威数据库SCIE收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映生物-内分泌学与代谢领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为27.7，平均审稿速度为 约2.5月 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。